Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 01/8/08 → 01/31/10 |
Funding
- Gilead Sciences Incorporated: $10,113.00
A Phase 1, Randomized, Double-blind, Placebo-controlled Assessment of the Safety, Tolerability, and Activity of GS-9191 Ointment for the Treatment of Genital Warts Caused by Human Papilloma Virus Infection
- Baker, David A. (PI)
- Figueroa, Reinaldo (CoPI)
- Johnson, Jennifer (CoPI)
Project: Research